Clostridioides difficile Infection in Patients after Organ Transplantation-A Narrative Overview.
- 2022-07-27
- Journal of clinical medicine 11(15)
- PubMed: 35955980
- DOI: 10.3390/jcm11154365
Study Design
- Type
- Review
- Population
- Solid-organ-transplant (SOT) patients and patients after hematopoietic stem cell transplantation
Clostridioides difficile infection (CDI) is one of the most common causes of antibiotic-associated diarrhea. The pathogenesis of this infection participates in the unstable colonization of the intestines with the physiological microbiota. Solid-organ-transplant (SOT) patients and patients after hematopoietic stem cell transplantation are more prone to CDI compared to the general population. The main CDI risk factors in these patients are immunosuppressive therapy and frequent antibiotic use leading to dysbiosis. The current review article provides information about the risk factors, incidence and course of CDI in patients after liver, kidney, heart and lung transplantation and hematopoietic stem cell transplantation.